Report Categories
View AllRecent Articles
View All
Xenon Pharmaceuticals XENE Unveils Robust Azetukalner Phase III Data Q3 NDA Filing Plans at Bloom Burton Conference
Should you add LZ LZMH to your watchlist today 495 20260508
What capacity utilization NextCure NXTC 247 20260427
ACRD ACRES D Pref latest quarterly earnings release shares no core financial metrics amid ongoing internal reviews